Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/24 17:40 | 5/20/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | 8 | S.edm | -1,831 | 16.39 | 0 | -112 | 868 | D | ||||||||||||||||
2/12/24 19:51 | 2/8/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | Maltbie Shane | MA | O | CFO | 1 | S.d | -53 | 14.93 | 0 | -4 | 88 | D | |||||||||||||||
2/12/24 19:47 | 2/8/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | MA | DO | See Rema | 1 | S.d | -173 | 14.93 | 0 | -12 | 1,128 | D | |||||||||||||||
2/12/24 19:35 | 2/8/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | Borkowski Astrid | MA | O | Chief Me | 5 | S.dm | -706 | 14.42 | 0 | -49 | 215 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |